.Technology has transformed almost every single aspect of our lives. Yet in biopharma, it still takes 12 years to develop a drug. Even today, thousands of diseases affecting hundreds of millions of people have no effective treatment. Accelerating the pace of bringing effective, new medicines to patients is one of the greatest opportunities for humanity. Our mission is to develop better drugs, faster using technology. We have built an end-to-end technology-driven drug discovery platform centered around one of the field's largest human genomics databases in neuroscience. We use machine learning to map the complex causes of disease and turn those insights into promising drug candidates on our internal biology and chemistry platforms. We are developing drugs to treat some of the biggest medical challenges today: ALS, Parkinson's disease, and dementia. Our first drug entered the clinic in 2022 as a new treatment for ALS and was discovered entirely from our platform. We have raised $175M from top tier investors (e.G. BlackRock, Eli Lilly, Merck, Section 32, Threshold Ventures, Y Combinator, etc.). We are a team of engineers, neuroscientists, and drug developers united around an audacious vision: to build the next Genentech of the digital age.Who You Are:Verge Genomics is a leading innovator in the life sciences and biotech industry, dedicated to advancing scientific research and delivering groundbreaking therapies. We are committed to fostering a collaborative and dynamic work environment where employees can thrive and make a meaningful impact. As an Accountant at Verge, you will be responsible for developing, implementing and maintaining our accounting systems. You will play a crucial role in ensuring the accuracy and compliance of financial records, preparing essential financial statements, and supporting the overall financial health of the company.Accountant Location RemoteDescription Who We Are:Technology has transformed almost every single aspect of our lives. Yet in biopharma, it still takes 12 years to develop a drug. Even today, thousands of diseases affecting hundreds of millions of people have no effective treatment. Accelerating the pace of bringing effective, new medicines to patients is one of the greatest opportunities for humanity. Our mission is to develop better drugs, faster using technology. We have built an end-to-end technology-driven drug discovery platform centered around one of the field's largest human genomics databases in neuroscience. We use machine learning to map the complex causes of disease and turn those insights into promising drug candidates on our internal biology and chemistry platforms. We are developing drugs to treat some of the biggest medical challenges today: ALS, Parkinson's disease, and dementia. Our first drug entered the clinic in 2022 as a new treatment for ALS and was discovered entirely from our platform. We have raised $175M from top tier investors (e.G
